Research by Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active ...

Thirty years after the sequencing of the BRCA1 cancer-associated gene, access to genetic tests and awareness about its risks ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

As a doctor working in the NHS, I see with my own eyes that cancer is on the rise. Today, figures show it affects one in two ...

African men have a high risk of prostate cancer. Research has found genetic regions associated with this disease.

Advances in our research are helping men live longer and with a better quality of life. With your support, we will continue ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris ...

Myriad’s full suite of urologic oncology products is uniquely aligned with the updated NCCN Guidelines, offering integrated genetic and tumor genomic insights that identify germline risk, provide ...

As research highlights genetic risks for African men, early testing for prostate cancer is vital and needn’t be invasive.

Early testing is key to addressing the rise in cases of prostate cancer in Africa - and it doesn't have to be an invasive procedure. That's the message from cancer survivors and health experts on the ...

(NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic test continues to be classified by the National Comprehensive ...